53 Biggest Movers From Yesterday



  • Longeveron Inc. LGVN shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with mild Alzheimer's disease in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
  • SAB Biotherapeutics, Inc. SABS jumped 44.6% to settle at $3.76. SAB Biotherapeutics posted a FY21 net loss of $17.1 million.
  • Integrated Media Technology Limited IMTE climbed 38.3% to settle at $31.14.
  • Jaguar Health, Inc. JAGX jumped 32.3% to close at $0.7085 after the company announced an agreement granting Quadri Pharmaceuticals for exclusive promotional, commercialization and distribution rights for specified human indications of crofelemer in the Middle East.
  • Icosavax, Inc. ICVX shares gained 32.1% to close at $7.04 following Q4 results.
  • CPS Technologies Corporation CPSH gained 27.1% to close at $5.21.
  • Trevena, Inc. TRVN surged 24.6% to close at $0.5499 after the company reported Q4 earnings results and entered into a royalty-based financing agreement of up to $40 million with an affiliate of R-Bridge Healthcare Fund.
  • Clovis Oncology, Inc. CLVS jumped 22.4% to close at $2.02 as the company announced positive topline data from the monotherapy arm of Phase 3 ATHENA-MONO trial of Rubraca (Rucaparib) as first-line maintenance treatment in ovarian cancer.
  • iSpecimen Inc. ISPC gained 20.1% to close at $5.37.
  • TMC the metals company Inc. TMC jumped 19.4% to settle at $2.59 following circulation of a letter from the company's CEO to a member of the Senate Committee on Energy and Natural Resources.
  • DURECT Corporation DRRX gained 17.5% to close at $0.6699.
  • Inspirato Incorporated ISPO rose 16.3% to close at $9.94.
  • Vertex Energy, Inc. VTNR gained 15.5% to close at $9.94.
  • Crinetics Pharmaceuticals, Inc. CRNX jumped 15.5% to settle at $21.95 after the company reported Q4 earnings results and top-line results from its Phase 1 clinical study of CRN04777.
  • IZEA Worldwide, Inc. IZEA climbed 15.3% to close at $1.66 after the company reported Q4 EPS results up from last year and better-than-expected sales results.
  • Nano-X Imaging Ltd. NNOX climbed 15.1% to close at $10.84 after the company reported better-than-expected Q4 EPS and sales results.
  • Creative Medical Technology Holdings, Inc. CELZ gained 15% to close at $3.90 after the company announced it signed a Master Collaboration Agreement with the University of Miami to accelerate development of its ImmCelz Supercharged Autologous Immunotherapy Platform.
  • NextPlat Corp NXPL jumped 15% to close at $3.06.
  • RCM Technologies, Inc. RCMT climbed 14.9% to close at $9.86 after the company reported Q4 results.
  • Vector Group Ltd. VGR surged 13.6% to close at $12.04 after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $16.
  • American Resources Corporation AREC jumped 11.7% to close at $2.57.
  • Local Bounti Corporation LOCL gained 11.6% to close at $8.49. Local Bounti recently agreed to acquire California-based complementary indoor farming company Hollandia Produce Group Inc, which operates under the name Pete's, for $122.5 million.
  • BioAtla, Inc. BCAB climbed 8.9% to close at $5.00.


Don’t forget to check out our premarket coverage here .


  • Motorsport Games Inc. MSGM fell 35.9% to close at $1.32 on Thursday after the company reported Q4 financial results. Canaccord Genuity and Benchmark downgraded the stock.
  • Missfresh Limited MF fell 29.4% to settle at $0.9042.
  • Clarus Therapeutics Holdings, Inc. CRXT dipped 28.4% to close at $1.49 after the company reported Q4 earnings results.
  • Sky Harbour Group Corporation SKYH fell 28% to close at $14.92.
  • Acutus Medical, Inc. AFIB fell 28% to settle at $1.39 after the company reported worse-than-expected Q4 EPS results and issued Q1 sales guidance below analyst estimates.
  • SOS Limited SOS dipped 27.3% to close at $0.5366 after the company announced pricing of a roughly $20 million registered direct offering.
  • Arcadia Biosciences, Inc. RKDA shares dipped 25.9% to settle at $1.40 as the company reported fourth-quarter revenue declined 70% year-over-year to $2.17 million, missing the consensus of $3.33 million.
  • UiPath Inc. PATH shares fell 25.7% to close at $21.59. UiPath reported upbeat results for its fourth quarter on Wednesday, but issued weak sales guidance.
  • Sharecare, Inc. SHCR dropped 25.2% to close at $2.47 after the company reported worse-than-expected Q4 sales results and issued Q1 and FY22 sales guidance below estimates.
  • Rail Vision Ltd. RVSN dropped 25% to close at $3.09 on Thursday as the company priced its IPO at $4.13 per unit.
  • InflaRx N.V. IFRX fell 23.4% to close at $1.83 as the company announced topline data from Phase 3 part of Phase 2/3 PANAMO study of vilobelimab in critically ill COVID-19 patients.
  • Meiwu Technology Company Limited WNW dropped 22.2% to close at $0.8797.
  • Oxbridge Re Holdings Limited OXBR shares fell 21.3% to close at $5.47
  • after the company reported results for the fourth quarter.
  • Hillstream BioPharma, Inc. HILS shares fell 21.2% to close at $1.60 after jumping 39% on Wednesday.
  • Terran Orbital Corporation LLAP dropped 21% to close at $6.88.
  • Genetron Holdings Limited GTH fell 20.9% to close at $2.19.
  • Cyren Ltd. CYRN dipped 20.6% to close at $5.05.
  • VNET Group, Inc. VNET dipped 18.1% to close at $1.83. VNET Group posted Q4 loss of $0.24 per share.
  • Locafy Limited LCFY fell 16.4% to close at $2.3405.
  • 111, Inc. YI dropped 16.4% to settle at $2.66.
  • Stronghold Digital Mining, Inc. SDIG dipped 16.1% to close at $5.85.
  • Synthetic Biologics, Inc. SYN fell 15.1% to close at $0.2853.
  • DiDi Global Inc. DIDI fell 15% to close at $2.50.
  • NRx Pharmaceuticals, Inc. NRXP dropped 14.1% to close at $2.45 after the company reported FY21 earnings results. The company also reported its nebulized form of aviptadil in the I-SPY COVID Trial has been stopped.
  • Revelation Biosciences, Inc. REVB fell 13.6% to close at $1.14. Revelation Biosciences recently said its Phase 2b viral challenge study to evaluate the efficacy of intranasal REVTx-99a did not meet its primary endpoint.
  • Akebia Therapeutics, Inc. AKBA dropped 13.4% to close at $0.7179. Akebia Therapeutics recently said the FDA issued a complete response letter to the company's New Drug Application for vadadustat.
  • Vyant Bio, Inc. VYNT shares fell 11.2% to close at $1.43. Vyant Bio shares jumped over 19% on Wednesday after the company announced a strategic collaboration to discover therapeutics to treat Parkinson's Disease and reported Q4 earnings results.
  • U.S. Well Services, Inc. USWS fell 9.1% to close at $1.10 as the company posted a loss for its fourth quarter, while sales missed estimates.
  • Auddia Inc. AUUD dropped 8.9% to close at $2.04.
  • China SXT Pharmaceuticals, Inc. SXTC fell 7.4% to close at $0.28.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasMovers From YesterdayTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!